Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

Abstract Background Direct oral anticoagulants (DOAC) including edoxaban are increasingly used for stroke prevention in atrial fibrillation. Despite treatment, annual stroke rate in these patients remains 1–2%. Rapid assessment of coagulation would be useful to guide thrombolysis or reversal therapy...

Full description

Bibliographic Details
Main Authors: Florian Härtig, Ingvild Birschmann, Andreas Peter, Sebastian Hörber, Matthias Ebner, Matthias Sonnleitner, Charlotte Spencer, Paula Bombach, Maria-Ioanna Stefanou, Johannes Tünnerhoff, Annerose Mengel, Joachim Kuhn, Ulf Ziemann, Sven Poli
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Neurological Research and Practice
Subjects:
Point-of-care testing
POCT
Direct oral anticoagulants
DOAC
Non-vitamin K antagonist oral anticoagulants
NOAC
Online Access:https://doi.org/10.1186/s42466-021-00105-4

Internet

https://doi.org/10.1186/s42466-021-00105-4

Similar Items